Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00240227 · ClinicalTrials.gov registry record · NA
Prazosin for ETOH or Cocaine Craving
A NA study, sponsored by US Department of Veterans Affairs.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00240227 is a NA study that was terminated before completion, run by US Department of Veterans Affairs. The registered enrollment target is 8 participants.
The verdict
NCT00240227, a NA study, was terminated before completion, sponsored by US Department of Veterans Affairs.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This double-blind placebo controlled crossover pilot trial will test the hypothesis that prazosin, an alpha-1 adrenergic receptor antagonist, reduces craving for their drug of choice in cocaine-dependent and alcohol-dependent veterans. Both the study medication period and the placebo period are each 4 weeks in duration.
Interventions
- DRUG placebo
- DRUG Prazosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2004-04 |
| Est. Completion | 2009-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00240227
The ClinicalTrials.gov registry entry for NCT00240227 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00240227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00240227 about?
NCT00240227 is a clinical study titled "Prazosin for ETOH or Cocaine Craving". This double-blind placebo controlled crossover pilot trial will test the hypothesis that prazosin, an alpha-1 adrenergic receptor antagonist, reduces craving for their drug of choice in cocaine-dependent and alcohol-dependent veterans. Both the study medication period and the placebo period are each...
What is the current status of trial NCT00240227?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2004-04. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00240227?
The interventions under investigation include: placebo (DRUG), Prazosin (DRUG).
Who is sponsoring clinical trial NCT00240227?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.